W ith increasing life span as afforded by nutritional, technological, and therapeutic advancements during the last century, cardiac diseases have moved to the top of morbidity and mortality statistics and progressed into a significant socioeconomic burden. Accordingly, efforts have been substantial to understand the development of heart failure as the final disease state in a sequence of events initiated by a variety of etiologies ranging from ischemic heart disease to idiopathic cardiomyopathies, hereditary diseases, and senescence. In respect to cardiac arrhythmogenesis, these studies were primarily focused on the elucidation of parenchymal cell dysfunction and included topics such as impairment of ion-channel function, reduced gap junctional coupling, and abnormal calcium handling of cardiomyocytes.
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By contrast, the involvement of stromal cells in the initiation and maintenance of cardiac arrhythmias has been less aggressively pursued. This is likely due to the circumstance that at first glance, stromal cells seem to be less "exciting" than their parenchymal counterparts, which exhibit electric and contractile activity. This perception has started to change considerably during the last decade, however, and it is the goal of this short review to summarize recent findings that shed new light onto potential roles played by cardiac fibroblasts, and in particular myofibroblasts, in the development of the arrhythmic heart.
Cardiac Fibroblasts: Structure, Function, and 3-Dimensional Organization
In normal hearts, fibroblasts outnumber cardiomyocytes by a factor of 2 to 3. 1 Scanning electron microscopic studies show fibroblasts to be spindle-like, slender cells that link up to each other by filopodia, whereby they form an interconnected 3-dimensional network of cells that surrounds cardiomyocytes in a regular fashion ( Figure 1 ). 2 Similar to other tissues such as the skin, fibroblasts in the heart form a functional syncytium by expressing intercellular channels (gap junctions) at sites of cell-to-cell contacts. 2, 3 The ability of fibroblasts to also establish functional heterocellular gap junctional coupling with cardiomyocytes in vivo is still under debate, however, and awaits the development of suitable experimental methodologies, which will permit the investigation of such coupling in intact tissue. The formation of a 3-dimensional cellular network by fibroblasts is a prerequisite for this cell type to accomplish its main task in the heart, that is, the generation and maintenance of a regular 3-dimensional network of extracellular structural proteins that consists primarily of fibrillar collagen (type IϾ Ͼtype III) and to a lesser degree of fibronectin, laminin, and elastic fibers. 4, 5 This "heart skeleton" has 2 main functions: (1) it serves as a scaffold for cardiomyocytes that integrates contractile forces of individual cells as to result in an efficient pump function of the entire organ, and (2) it ensures long-term integrity of the orderly 3-dimensional cellular architecture of cardiomyocytes, which itself is a prerequisite for the fast and uniform electric activation of the heart. 6 Somewhat contrary to expectations, the heart skeleton does not represent a static entity but is subject to continuous turnover, which is largely under the control of fibroblasts that synthesize and secrete collagens, matrix metalloproteinases, and tissue inhibitors of metalloproteinases. 7 Previously reported turnover rates of collagen in the heart range from 0.6% to 5% per day. 8, 9 Interestingly, a recent study comparing turnover rates of collagens in different human tissues found that it is fastest in the heart with cardiac collagen reaching a mean age of Ϸ40 days (turnover rates: heartϾarteriesϾskeletal muscleϾlungϾ Ͼbone, dermis). 10 Even though this may appear slow compared with turnover rates of other cellular proteins (which can be a few hours or less), it is still significant and indicates that fibroblast function must be tightly controlled to ensure long-term collagen homeostasis that is prerequisite for the preservation of the heart skeleton.
Categories of Arrhythmogenic Fibroblast-Cardiomyocyte Interactions
Within the working myocardium, there exist at least 4 distinct possibilities of interactions between fibroblasts and cardiomyocytes that may result in altered cardiac function in general and arrhythmogenesis in particular: (1) abnormal increase in connective tissue, (2) paracrine interactions, (3) mechano-electric feedback, and (4) direct electrotonic interactions. To date, there exists a wealth of information regarding the role of the fibrotically remodeled myocardium in arrhythmogenesis. However, our understanding of the role and relative importance played by the 3 remaining mechanisms in the generation and maintenance of cardiac arrhythmias is still limited. In this review, all 4 possibilities of arrhythmogenic interactions will be briefly reviewed, with particular emphasis given to the intriguing possibility of arrhythmogenic myofibroblast-cardiomyocyte interactions elicited by electrotonic cross-talk.
Fibrosis and Arrhythmogenesis
Cardiac fibrosis plays a central role in the development of electric and mechanical dysfunctions of the heart. 11 The main causes of cardiac fibrosis include mechanical overload of the heart, infarction, genetic predisposition, and old age, where the latter factor gains increasing importance with increasing life expectancy. 12 The disproportionally large deposition of extracellular matrix proteins (ECM) typical for fibrosis not only compromises cardiac pump function, but by disrupting the orderly 3-dimensional cytoarchitecture of electrically coupled cardiomyocytes, causes arrhythmogenic alterations in the excitable substrate that ultimately leads to abnormal impulse generation and propagation. 6 Excess ECM proteins in the fibrotically remodeled myocardium form electrically insulating laminae that force impulse conduction to follow tortuous pathways resulting in slow overall conduction, discontinuous conduction, and conduction blocks. 13, 14 The severity of these conduction disturbances is dependent on the amount and specific spatial distribution of excess connective tissue within the working myocardium, which is categorized into interstitial, compact, diffuse, and patchy fibrosis, as illustrated in Figure 2 . 15 Compact fibrosis formed by healed infarct scars is in fact the least arrhythmogenic despite its gross structural appearance, because reentry can only occur around the area of fibrosis and, accordingly, is only rarely observed in humans. 16 In patchy fibrosis as well as in severe interstitial fibrosis, bundles of cardiomyocytes are separated over extended distances by collageneous septa, resulting in tortuous activations of the electric substrate ("zig-zag" conduction). This fibrotic texture is known to be highly vulnerable to arrhythmias. 14 Finally, in diffuse fibrosis, collageneous septa are relatively short and thus have a lesser impact on conduction. However, if fibrosis is severe, this texture can induce arrhythmogenic slow conduction that favors spiral wave formation. 17 Apart from causing abnormal conduction patterns, fibrosis also eases abnormal impulse generation because the success of a putative ectopic focus to drive the surrounding myocardium is dependent on the degree of electrotonic coupling of this focus to the surrounding normally polarized myocardium. 18, 19 If the focus consists of a limited number of cells that are enveloped by electrotonically well-coupled cardiomyocytes, the latter will prevent the focus from discharging by clamping its constituent cells to a steady potential. If, however, electrotonic coupling to neighboring cardiomyocytes is compromised by intercalated and electrically insulating collageneous laminae, the clamp may become ineffective and successful ectopic activation of the myocardium will ensue. 20 An important question in the context of fibrotic remodeling of the myocardium concerns the cell types responsible for excess ECM production. Whereas definite answers are still 
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Arrhythmogenic Stroma-Parenchyme Cross-Talk missing, there is consensus that so-called myofibroblasts (also termed activated fibroblasts) contribute substantially to fibrogenesis. 21 Myofibroblasts are not normally present in the working myocardium but typically appear in the wake of insults to the heart such as mechanical overload and infarction ( Figure 3 ). 22 Myofibroblasts are thought to derive from resident fibroblasts undergoing a phenotype switch (fibroblastϾprotomyofibroblastϾmyofibroblast), 23 from circulating fibrocytes and other progenitor cells and from cells undergoing epithelial-to-mesenchymal transition. Myofibroblasts differ from fibroblasts by the expression of ␣-smooth muscle actin, which conveys increased contractility to this cell type that is essential, for example, for scar retraction in skin wounds. 24 In analogy, myofibroblasts present at high densities in healing cardiac infarcts are thought to be responsible for infarct scar consolidation. 25 Similar to fibroblasts, myofibroblasts synthesize collagens types I and III, thereby supporting excess matrix deposition. 24, 26 Moreover, myofibroblasts represent a rich source of cytokines and growth factors, for many of which they also possess receptors (http://www.copewithcytokines.org and Powell et al). 27 Among these factors, transforming growth factor-␤1 (TGF-␤1) plays a central role by acting as a potent activator of fibroblasts and by inducing their transformation into myofibroblasts. Other humoral factors involved in fibroblast activation and consecutive collagen overproduction include angiotensin II (Ang II), endothelin-1, fibroblast growth factor 2, connective tissue growth factor, platelet-derived growth factor, insulin-like growth factor, and several interleukins. 28 -32 Based on the well-recognized arrhythmogenic potential of the fibrotically remodeled myocardium, therapeutic efforts to counteract this condition by either suppressing fibroblast collagen production or by interfering with collagen degradation are substantial. Central to these efforts is the renin-angiotensin-aldosterone system (both local and systemic), which is well established to play a key role in excess collagen production by fibroblasts. 33 Individual suppression of the renin-angiotensin-aldosterone system at different levels (angiotensin-converting enzyme inhibition, angiotensin receptor block, mineralcorticoid receptor block) and combination therapies have been demonstrated to exert beneficial effects on fibrosis and attenuation of arrhythmogenesis in animal models of senescence and in clinical studies in which these drugs are approved for treatment of heart failure. 34 -40 Statins represent a further class of drugs that have been shown to attenuate cardiac fibrosis in animal models of hypertrophic cardiomyopathy, infarction, and hypertension. Mechanisms underlying the effects of statins probably include pleiotropic effects ranging from improvement of endothelial dysfunction to anti-inflammatory and antiapoptotic activity as well as a modulation of TGF-␤1 levels. [41] [42] [43] [44] Suppression of TGF-␤1 also appears to contribute to the antifibrotic effect of pirfenidone, an orally active modified methyl-phenylpyridine that has been shown to reduce fibrosis and to decrease vulnerability to arrhythmias in animal models of congestive heart failure, infarction, and hypertension. [45] [46] [47] Pirfenidone has recently been approved for treatment of idiopathic pulmonary fibrosis in humans, which will provide interesting insight into its effect on cardiac fibrosis in future clinical studies.
Cardiac fibrosis, even though representing the most thoroughly investigated mechanism of arrhythmogenic fibroblastcardiomyocyte interactions, still poses a number of fundamental questions. Given the substantial turnover of collagens, how is the activity of fibroblasts fine-tuned to result in a well-balanced collagen metabolism under physiological conditions? How much of this control is intrinsic to the heart and how much is under systemic control? To which extent do myofibroblasts participate in excess production of collagen? Are recently discovered intracardiac angiotensinergic nerves involved in controlling the activity of fibroblasts? 48 What mechanisms underlie the chamber specific differences in propensity to develop fibrosis during mechanical overload? Finding answers to these and related questions are pivotal for a comprehensive understanding of the functional interactions between stromal and parenchymal cells in both cardiac health and disease. This knowledge will in turn be indispensable for the development of therapies targeted at curing mechanical and electric dysfunctions of the heart caused by fibroblast and/or myofibroblast dysfunction.
Paracrine Arrhythmogenic Fibroblast-Cardiomyocyte Interactions
Because stromal cells are literally squeezed in between individual parenchymal cells and because both cell types secrete and respond to a variety of humoral factors, it is tempting to speculate that paracrine interactions might exert direct proarrhythmic or antiarrhythmic effects on the ion channel repertoire of cardiomyocytes apart from their established involvement in controlling cell proliferation and hypertrophy. 40, 49 Currently there exists little direct evidence in favor of this assumption in intact tissue, but studies in vitro suggest that paracrine fibroblast-cardiomyocyte interactions can cause alterations in cardiomyocyte electrophysiology. When cultured in the presence of cardiac fibroblast conditioned medium, it was found that gene expression for the fast sodium inward current Nav1.5 and the inward rectifier potassium channel Kir2.1 was substantially reduced resulting in partial loss of resting membrane polarization of cardiomyocytes and induction of slow conduction. Trypsin treatment abolished this effect, suggesting that it was due to a protein secreted by fibroblasts. 50 A reduction of Kv4.2 was found when exposing cultured neonatal rat cardiomyocytes to fibroblast-conditioned medium, which resulted in a significant reduction of the transient outward potassium current (I to ) and a prolongation of action potential duration. 51 Furthermore, fibroblast-conditioned medium was reported to stimulate the percentage of spontaneously beating cardiomyocytes with endothelin-1 secretion from fibroblasts probably being responsible for the observed effect. 52 In contrast, another study found no effects of fibroblast conditioned media on HL-1 cardiomyocyte monolayers. 53 Though the limited number of these partly controversial studies makes it difficult to draw firm conclusions as to the likelihood of an adverse ion channel remodeling of cardiomyocytes by paracrine fibro/ myofibroblast activity, this intriguing possibility demands further investigation as pronounced alterations in ion channel activity and/or expression were observed when cardiomyocytes were directly exposed to the following humoral factors known to be secreted by myofibroblasts:
Angiotensin II
As reviewed elsewhere, Ang II has a number of arrhythmogenic effects on cardiomyocytes. 54 -56 It was reported to increase Ca 2ϩ influx through L-type Ca channels, augment Ca 2ϩ release from the SR, increase sodium-calcium exchanger activity, enhance the delayed rectifier potassium current IKs (shortening of action potential duration), reduce I to (lengthening of action potential duration) and reduce gap junctional coupling.
Transforming Growth Factor-␤1
TGF-␤1 affects cardiomyocyte electrophysiology by decreasing gap junctional coupling, 57 increasing spontaneous Ca 2ϩ oscillations and the size of caffeine-sensitive stores, 58 and by reducing inward rectifying potassium currents, sodium inward currents and L-type Ca 2ϩ currents in atrial cardiomyocytes. 59, 60 For review, see also Ramos-Mondragón et al. 61 
Endothelin-1
Overexpression of endothelin-1 in mice causes substantial downregulation of connexin 40 and 43 protein expression and phosphorylation and reduces sodium inward currents resulting in QRS prolongation. 62, 63 Fibroblast Growth Factor-2 Fibroblast growth factor-2 was reported to cause activation of a voltage-independent calcium current, increase the level of connexin43 phosphorylation, and reduce metabolic coupling. 64, 65 Vascular Endothelial Growth Factor VEGF leads to an increase in Ca 2ϩ transient amplitude and an upregulation of connexin43 expression. 66 -68 Tumor Necrosis Factor-␣ TNF-␣ decreases I to and Kv4.2 expression, reduces delayed rectifier potassium currents, modulates ATP dependent potassium currents, and inhibits L-type Ca 2ϩ currents. 69 -74 This nonexhaustive list illustrates that a substantial number of humoral factors known to be secreted by myofibroblasts has the potential to cause complex and often adverse electric remodeling of cardiomyocytes. Accordingly, paracrine interactions between myofibroblasts and cardiomyocytes in diseased hearts might have the potential to contribute to the development of an arrhythmogenic substrate. Direct proof of the existence of such a mechanism must await the development of experimental methodologies suited to investigate paracrine interactions in intact hearts. Furthermore, when considering locally produced humoral factors to play a role in arrhythmogenesis, other cell types that are present in diseased hearts and that are known to secrete cytokines like macrophages, mast cells, and neutrophils must also be taken into consideration. 75
Arrhythmogenic Electro-Mechanical Feedback Between Fibroblasts and Cardiomyocytes
Cardiac fibroblasts were reported to respond to mechanical stress by altering their membrane potential such that it fluctuates synchronously with contractions of neighboring cardiomyocytes. 76 These fluctuations are mediated by a surprisingly rich repertoire of ion channels, exchangers, and pumps expressed by cardiac fibroblasts. It has been found that cardiac fibroblasts express voltage-gated K ϩ channels, inward rectifying K ϩ channels, large-conductance Ca 2ϩ -activated K ϩ channels, chloride channels, sodium channels, transient receptor potential channels, voltage-gated proton channels, sodium-calcium exchangers and sodium potassium ATPases (for review, see Yue et al). 77 Membrane potentials generally reported for isolated cardiac fibroblasts are in the range of Ϫ20 to Ϫ40 mV. On mechanical deformation, activation of stretch-sensitive channels permeable to cations leads to changes in membrane polarization. 78 Although the exact role played by these membrane potential fluctuations is still elusive, it is tempting to speculate that they constitute a
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Arrhythmogenic Stroma-Parenchyme Cross-Talk sensor for the contractile state and mechanical requirements of the working myocardium that serves to adapt fibroblast proliferation, biochemical signaling, and collagen production to the needs of contraction. Abnormal reactivity of this hypothetical control system could potentially contribute to arrhythmogenesis by causing excess deposition of extracellular matrix as discussed above. Apart from this speculative mechanism, mechanosensitivity of fibroblasts in the sinoatrial node has been suggested to contribute to the positive chronotropic response after volumeinduced stretch of the right atrium. 79 In the sinus node, it has been convincingly shown that fibroblasts establish functional gap junctional coupling among themselves and with adjacent pacemaking cells. 80 Because the discharge frequency of pacemaking cells is sensitive to alterations in their membrane polarization, membrane potential fluctuations of coupled fibroblasts can be expected to modulate this frequency by electrotonic cross-talk. Accordingly, fibroblast depolarization secondary to activation of mechanosensitive channels during atrial filling may cause a similar change in membrane polarization of pacemaking cells, resulting in an increased firing rate. If this sequence of events is operational in intact hearts, it would represent an elegant explanation for the Bainbridge reflex/respiratory sinus arrhythmia. 81 In addition to this mechanism in which a mechanical stimulus alters fibroblasts electrophysiology that subsequently affects the electrophysiology of electrotonically coupled cardiomyocytes, a recent in vitro investigation suggested yet another mechanism. In this study, myofibroblasts that were firmly attached to cardiomyocytes by adhesion junctions were reported to alter cardiomyocyte electrophysiology and induce arrhythmogenic slow conduction by exerting mechanical stress on cardiomyocytes that activated mechanosensitive channels. 82 This observation proposes an interesting variant of mechano-electric interactions because it is not dependent on heterocellular gap junctional coupling between myofibroblasts and cardiomyocytes. Whether and to which extent either of these two mechanisms of mechano-electric feedback between myo/fibroblasts and cardiomyocytes have direct arrhythmogenic consequences for the intact diseased heart is not yet known.
Arrhythmogenic Electrotonic Cross-Talk Between Fibroblasts and Cardiomyocytes
Electrotonic cross-talk between fibroblasts and cardiomyocytes was first systematically investigated nearly half a century ago. In 1969, Hyde and colleagues published a meticulous study in which they measured membrane potentials of cultured cardiac fibroblasts (Ϫ10 to Ϫ20 mV), of cardiomyocytes (Ϫ55 to Ϫ75 mV), and of cardiomyocytes in mixed cultures (Ϫ50 mV). 83 From the intermediate membrane potential in mixed cultures and determinations of length constants, they concluded that fibroblasts and cardiomyocytes are functionally coupled and influence each other by electrotonic interactions. This interpretation was supported by the observation that fibroblasts connecting spatially disjunct cardiomyocytes caused synchronization of spontaneous activity, a phenomenon also reported in the same year by a Japanese researcher. 84 After many years of relative silence, the topic of electrotonic cross-talk between fibroblasts and cardiomyocytes has regained substantial attention over the last decade when it was shown, as summarized below, that myofibroblasts coupled by gap junctions to cardiomyocytes have the potential to elicit arrhythmias by inducing slow conduction and ectopic activity. 85 When two cell types with different intrinsic membrane potentials are electrotonically coupled by gap junctions, their membrane potentials affect each other, with the less polarized cell becoming hyperpolarized and vice versa. The degree of hyperpolarization in one cell and depolarization in the other cell follows basic laws of physics and is, at first approximation, proportional to the relative sizes of the membrane resistance of each cell and the gap junctional resistance. Because the latter is always different from zero, membrane potentials of the two cells will converge but never reach identical values. Moreover, the cell with the smaller membrane resistance will show less membrane potential swing than the cell with the higher membrane resistance.
In the initial studies mentioned above, fibroblasts from primary 2-D cell culture were identified on the basis of morphological criteria, as observed in phase-contrast microscopy. Of note, in primary 2-D cell culture, it is well established in the meantime that cardiac fibroblasts tend to undergo a rapid phenotype switch to myofibroblasts. 86 As shown in Figure 4 , phenotypically transformed fibroblasts in cell culture express ␣-SMAdecorated stress fibers (the hallmark of myofibroblasts) 87 and vimentin but not desmin (VA type of myofibroblast). 88 These cells thus share the molecular markers of myofibroblasts in diseased hearts 89 and were shown in culture to establish gap junctional coupling with cardiomyocytes through connexin43 and connexin45 but probably not connexin40 ( Figure 4B ). 90 As outlined below, the presence of such heterocellular gap junctional coupling has substantial adverse consequences for impulse generation and propagation in networks of cardiomyocytes.
In models of the working myocardium consisting of tissue-engineered strands of ventricular cardiomyocytes, impulse propagation characteristics and in particular conduction velocities are similar to those measured in intact rat ventricles (Ϸ350 -400 mm/s in culture versus 390 mm/s in situ). 91 When these preparations are coated with increasing numbers of myofibroblasts, it was found that conduction velocity first increases and then decreases to values as low as Ϸ250 mm/s ( Figure 5 ). 90 This biphasic change is highly reminiscent of changes in conduction velocity observed when subjecting whole cardiac tissue to increasing concentrations of extracellular potassium, which identifies a gradual reduction of cardiomyocyte membrane polarization as the common underlying mechanism. 88 Indeed, although strands consisting of cardiomyocytes only exhibited a resting potential around Ϫ80 mV, coating of these preparations with increasing densities of myofibroblasts caused an exponential decay in resting polarization to ϷϪ55 mV ( Figure 5C ). This value rather closely reflects theoretically expected values when taking into consideration previously reported values for membrane resistances and resting polarizations of each cell type and gap junctional resistances for coupled cell pairs. The main consequence of the myofibroblast-induced decrease in membrane polarization of cardiomyocytes consists of a drastic reduction in sodium channel availability, which explains the observed slowing of conduction. 6 These findings suggest that regions in the heart where sufficiently large numbers of myofibroblasts are in close contact with cardiomyocytes (as happens to be the case in the border zone of healing infarcts) might cause substantial local slowing of conduction. This arrhythmogenic effect may reinforce other mechanisms known to disturb impulse conduction in the infarct border zone-like electric remodeling of cardiomyocytes and redistribution of gap junctions. 92, 93 The possibility that myofibroblasts might affect the resting polarization of border zone cardiomyocytes is indirectly supported by the observation 
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Arrhythmogenic Stroma-Parenchyme Cross-Talk that cardiomyocytes in close proximity to 5-day-old infarcts exhibit a reduced membrane potential, whereas after dispersion into single cells, they tend to display normal potentials. 94, 95 Apart from inducing slow conduction, myofibroblasts were also shown to induce ectopic activity after establishment of heterocellular gap junctional coupling with cardiomyocytes. As is illustrated in Figure 6 , it was found that dense monolayer cultures of cardiomyocytes remain completely quiescent unless exogeneously added myofibroblasts surpass a minimal density of 15%. 96 The percentage of preparations showing ectopic activity was dependent on myofibroblast densities, with nearly all preparations showing spontaneous activity when the cardiomyocyte surface was coated by Ϸ50% with myofibroblasts. Similar to myofibroblast-induced slow conduction, precipitation of ectopic activity was dependent on a critical reduction of cardiomyocyte polarization after establishment of heterocellular coupling with myofibroblasts thereby constituting a further example of the well established concept of "depolarization-induced automaticity." 97 A critical reduction of cardiomyocyte polarization may furthermore increase the chances of delayed afterdepolarizations to give rise to triggered activity because of the reduced inward current requirements to reach threshold. Moreover, it has recently been reported that coupling of a model of myofibroblasts to intact cardiomyocytes potentiates the occurrence of early afterdepolarizations, suggesting that myofibroblast-cardiomyocyte interactions may also facilitate the precipitation of triggered activity. 98 Of note, both slow conduction and ectopic activity can also be elicited with HeLa cells instead of cardiac myofibroblasts. Similar to myofibroblasts, connexin43-transfected HeLa cells exhibit a modest membrane polarization and readily establish heterocellular gap junctions with cardiomyocytes, thus supporting the mechanism operational in myofibroblast arrhythmogenicity. The HeLa cell experiments suggest that cell therapies with communication-competent cells that are moderately polarized as previously reported for human mesenchymal stem cells, 99 are potentially dangerous because, if present at sufficient densities, these cells may cause arrhythmogenic slow conduction and ectopic activity when electrotonically coupled to cardiomyocytes.
A third example illustrating potentially arrhythmogenic effects of myofibroblasts relates to their capacity to form passive conductors for excitatory current flow that enables Figure 7 . Impulse propagation characteristics in a tissue-engineered model of myocardial fibrosis. A, Schematic drawing of the model consisting of strands of cardiomyocytes (red) that are coated with a monolayer of myofibroblasts (green). B, Phase-contrast image of a preparation with 50-m-wide cardiomyocyte strands that are linked laterally by 50-m-wide bands of myofibroblasts. C, After stimulation at the site indicated by an asterisk, conduction along the cardiomyocyte strands was moderately slow, whereas transverse conduction became extremely slow resulting in an anisotropy ratio of Ϸ15. Modified from Rohr, with permission. 86 electric synchronization of cardiac tissue over distances as long as 300 m. 100 In principle, such synchronization might be beneficial for restoring conduction in fibrotic cardiac tissue known to be prone for conduction blocks. Also, it might be responsible for synchronization of electric activation between donor and recipient tissue after heart transplantation. 101 It has the distinct disadvantage, however, that conduction along the passive conductors consisting of myofibroblasts is characterized by substantial local activation delays that give rise to highly discontinuous slow conduction. In fact, in a model of fibrotic tissue consisting of strands of cardiomyocytes linked laterally to each other by myofibroblasts, macroscopic conduction across the fibroblast bridges became as slow as 14 mm/s, a value otherwise achieved only during critical gap junctional uncoupling (Figure 7 ). 102 Overall, electrotonic cross-talk between myofibroblasts and cardiomyocytes has a substantial arrhythmogenic potential because it induces uniform slow conduction, discontinuous slow conduction, and ectopic activity. Accordingly, and as recently confirmed in vitro, the combination of these conditions has a high probability to result in sustained reentrant activity whose complexity increases with increasing myofibroblast density ( Figure 8 ). 103 Of note, the basic mechanism underlying myofibroblast-induced slow conduction and generation of ectopic activity is in fact identical to the concept of arrhythmogenic "injury current" flow in the infarct border zone, the only difference being the cell type sourcing 
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Conclusion, Open Questions, and Perspectives
Cardiac fibroblasts play a pivotal role in the preservation of the normal structure and function of the heart by generating and maintaining an elaborate heart skeleton that ensures both stability of the cellular organization of the electric substrate and integration of contractile forces of individual cells to comply with the pump requirements. Maintenance of this skeleton is critically dependent on the delicate balance between secretion and degradation of its molecular components, which is tipped toward fibrosis by any major insult to the heart that causes activation of fibroblasts and their transformation into myofibroblasts secondary to mechanical cues, neurohumoral factors, and inflammation. Cardiac fibrotic remodeling resulting from fibroblast activation not only compromises mechanical pump function but is a powerful and well-established arrhythmogenic condition on its own due to its capacity to disrupt the normally uniform electric substrate for propagation. Going beyond this wellestablished indirect involvement of cardiac myofibroblasts in arrhythmogenesis, recent findings in tissue-engineered primary cell cultures gave rise to the novel concept that myofibroblasts have the potential to exert direct arrhythmogenic effects on cardiomyocytes, (1) by causing electric remodeling-based on paracrine interactions, (2) by affecting cardiomyocyte electrophysiology through electro-mechanical feedback, and (3) by acting as a source of injury current for cardiomyocytes. Whereas there exists circumstantial evidence that these 3 mechanisms might be operational in intact hearts, unequivocal proof is still missing on account of the current dearth of methodologies appropriate for directly investigating these mechanisms in intact tissue. In particular, the following questions are still unanswered: (1) What is the relative contribution of myofibroblasts versus fibroblasts to excess ECM deposition in fibrosis? (2) Is there a correlation between the density/spatial distribution of myofibroblasts and the frequency of occurrence of cardiac arrhythmias? (3) Do myofibroblasts also establish functional heterocellular gap junctions with cardiomyocytes in vivo? What is the conductance of these junctions? (4) What ion channel repertoire do myofibroblasts exhibit in vivo? Is it different from fibroblasts, and is it appropriate to give rise to injury currents of sufficient magnitude as to successfully induce slow conduction and ectopic activity? Finding answers to these questions will be vital for arriving at a comprehensive understanding of the mechanisms and relative importance of the 4 different modalities whereby stromal cells, as summarized in Figure 9 , may provoke cardiac arrhythmias by interacting directly or indirectly with cardiomyocytes. It is likely that the respective investigations will contribute to the identification of novel therapeutic targets that are suitable to suppress cardiac arrhythmias and that will halt or even reverse the progression from heart disease to heart failure.
